Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytochrome P450 3A pharmacogenetics: the road that needs traveled.

× No keyword cloud information.

11 in total

1. Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.

Authors: Yuanyuan Dong; Huasheng Xiao; Qi Wang; Chunxiu Zhang; Xiuming Liu; Na Yao; Haihui Sheng; Haiyan Li
Journal: Int J Clin Exp Med Date: 2015-10-15

2. Higher plasma bilirubin predicts veno-occlusive disease in early childhood undergoing hematopoietic stem cell transplantation with cyclosporine.

Authors: Kwi Suk Kim; Aree Moon; Hyoung Jin Kang; Hee Young Shin; Young Hee Choi; Hyang Sook Kim; Sang Geon Kim
Journal: World J Transplant Date: 2016-06-24

Review 3. Adjuvant pharmacotherapy in the management of elderly patients with pancreatic cancer.

Authors: Raphaël Maréchal; Anne Demols; Jean-Luc Van Laethem
Journal: Drugs Aging Date: 2013-03 Impact factor: 3.923

Review 4. Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects.

Authors: J L Pilgrim; D Gerostamoulos; Olaf H Drummer
Journal: Forensic Sci Med Pathol Date: 2010-11-04 Impact factor: 2.007

Review 5. The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis.

Authors: Jiezhong Chen; Kong-Nan Zhao; Chen Chen
Journal: Ann Transl Med Date: 2014-01

Review 6. Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors: Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal: Pharmacogenomics Date: 2009-12 Impact factor: 2.533

7. Medication use in breast cancer survivors compared to midlife women.

Authors: Julie L Otte; Todd C Skaar; Jingwei Wu; Menggang Yu; Kristin Ryker; Debra S Burns; Janet S Carpenter
Journal: Support Care Cancer Date: 2013-02-10 Impact factor: 3.603

8. Effect of breviscapine on CYP3A metabolic activity in healthy volunteers.

Authors: Xuan Zhou; Yang-Yang Gao; Jian-Yong Hu; Yu Dong; Hai-Zhu Zhang; Yong Lai
Journal: Eur J Clin Pharmacol Date: 2017-10-06 Impact factor: 2.953

9. Association of CYP2C192 and ALDH1A11/*2 variants with disease outcome in breast cancer patients: results of a global screening array.

Authors: Sourav Kalra; Raman Preet Kaur; Abhilash Ludhiadch; Gowhar Shafi; Rajesh Vashista; Raj Kumar; Anjana Munshi
Journal: Eur J Clin Pharmacol Date: 2018-06-24 Impact factor: 2.953

10. Pharmacogene regulatory elements: from discovery to applications.

Authors: Robin P Smith; Ernest T Lam; Svetlana Markova; Sook Wah Yee; Nadav Ahituv
Journal: Genome Med Date: 2012-05-25 Impact factor: 11.117

Cytochrome P450 3A pharmacogenetics: the road that needs traveled.